At a glance
- Originator Curis
- Developer Curis; Johns Hopkins University School of Medicine
- Class Alkaloids; Antineoplastics; Small molecules
- Mechanism of Action Hedgehog cell-signalling pathway inhibitors
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Discontinued Breast cancer; Cancer